Transthyretin Cardiac Amyloidosis in HFpEF

Summary

To estimate the prevalence of transthyretin cardiac amyloidosis (TTR-CA) among Heart Failure with Preserved Ejection Fraction (HFpEF) patients with increased LV wall thickness in Southeast Minnesota using 99mTc-PYP single-photon positive emission computed tomography with computed tomography (SPECT/CT).

Timeline

Start

2017-12-01

Primary completion

2020-03-31

Completion

2020-03-31

Drugs

Indications